December 6 - 9, 2007
Hyatt Regency San Francisco
San Francisco, California
María A. Blasco, Spanish National Cancer Center, Madrid, Spain
Woodring E. Wright, UT Southwestern Medical Center, Dallas, TX
Virginia A. Zakian, Princeton University, Princeton, NJ
A key advance in the understanding of cellular senescence, immortalization, cancer, and aging came from the demonstration that the immortal growth of eukaryotic cells requires the maintenance of telomeric DNA. During the last decade, telomeres and telomerase have been suggested as therapeutic targets for both cancer and aging. In spite of recent advances, there are still many gaps in our understanding of the basic biology of telomeres and telomerase, which is fundamental to interpreting their role in human disease.
This was the third AACR Special Conference to bring together basic, translational, and clinical experts to present the latest developments in the field of telomeres and telomerase, which will help advance the development of different anti-cancer therapies. A new feature for this year's conference was the addition of experts working on DNA repair, chromatin, and stem cells who spoke about their research in the context of how it impacts telomere biology.
Please visit the AACR Meetings & Workshops Calendar for a complete list of upcoming programs.